Vertex secures EC approval of KALYDECO for infants with Cystic Fibrosis
CF is a rare, progressive, multi-system genetic disease that affects the lungs, liver, GI tract, sinuses, sweat glands,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Dec 19
CF is a rare, progressive, multi-system genetic disease that affects the lungs, liver, GI tract, sinuses, sweat glands,…
The chief executive of the General Pharmaceutical Council says companies supplying prescription drugs online need to be professional…
While e-pharmacies have made obtaining prescription drugs cheaper and easier, MedExpress founder Dwayne D'Souza says patient safety is…
06 Dec 19
Lynparza is an advanced PARP inhibitor, used for treating advanced ovarian cancer and metastatic breast cancer
05 Dec 19
Tecentriq binds with PD-L1, a protein expressed on tumour cells and tumour-infiltrating immune cells, to activate T cells…
28 Nov 19
Incyte is seeking approval of pemigatinib for cholangiocarcinoma on the basis of data from the phase 2 FIGHT-202…
26 Nov 19
Risdiplam is an orally administered liquid, designed to increase and sustain SMN protein levels both in the central…
21 Nov 19
GIVLAARI is an RNAi therapeutic designed to target aminolevulinic acid synthase 1 (ALAS1) for the treatment of adults…
20 Nov 19
Daratumumab is a biologic intended to target CD38, a surface protein that is highly expressed across multiple myeloma…
18 Nov 19
The study has reached the primary endpoint and has shown consistent safety results of the individual medicines with…